Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Parallel, Multi-center, Active Controlled, Single Blind (Assessor), Phase 3 Clinical Trial in Bowel Preparation for Colonoscopy

NCT06317350 is registered in ClinicalTrials.gov with Gunkang Pharmaceuticals, Inc as lead sponsor.

NCT NCT06317350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06317350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Parallel, Multi-center, Active Controlled, Single Blind (Assessor), Phase 3 Clinical Trial in Bowel Preparation for Colonoscopy
Lead sponsor
Gunkang Pharmaceuticals, Inc
Phase
Phase 3
Overall status
Completed
Start date
March 11, 2024
Completion date
October 16, 2024
Enrollment
318 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bowel preparation, colonoscopy